AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt
Key takeaways:
Vaccine maker AIM has filed for an IPO in Hong Kong, following unsuccessful previous bids in Hong Kong and on Shenzhen’s ChiNext board
The company has three Covid vaccines under development, including an mRNA vaccine expected to hit the market in the fourth quarter
By Fai Pui
China Q1 GDP Defies COVID-19 Impact But March Data Begins To Reflect Softness: What You Need To Know
China grew at a faster-than-expected clip in the first quarter, belying widespread fears that the COVID-19-induced shutdowns may have hurt the economy.
Infosys, HDFC Bank Drag Indian Stocks Down Sharply: What’s Behind Today’s Plunge?
Indian markets opened deep in red on Monday amid weak global cues, with the benchmark S&P BSE Sensex plunging over 1,100 points, or nearly 2%.
Why Alibaba And Other Stocks Are Not Trading In Hong Kong Today
Shares of U.S.-listed Chinese companies Alibaba Group Holdings Ltd. (NYSE: BABA), JD.Com Inc. (NASDAQ: JD), Nio Inc. (NYSE:
Me-ow! Pet Community Operator Boqii Faces Delisting Due to Shriveling Valuation
Key Takeaways:
Boqii could face delisting from the NYSE after its market valuation fell out of compliance with NYSE rules
Company could delist through a management-led buyout and is likely to disappear from the NYSE main board within the next year
By Doug Young
Call it the incredible shrinking pet.
Why Alibaba And Other Stocks Are Not Trading In Hong Kong Today
Shares of US-listed Chinese companies – Alibaba Group Holdings Ltd. (NYSE: BABA), JD.Com Inc. (NASDAQ: JD), Nio Inc.
Indian EV Entrepreneur Adopts Elon Musk’s Strategy: Devote More Time On Engineering And Leave Operations To Others
Following in the footsteps of Tesla Inc.
Why Cathie Wood Says Nio, Xpeng Could Be Immune To Chinese Regulatory Crackdown
U.S.-listed Chinese electric vehicle startups Nio, Inc. (NYSE: NIO) and XPeng, Inc.
Zhihu in Quest to Be First Internet Firm with U.S., Hong Kong Primary Listings
Key takeaways:
Zhihu will make a second primary listing in Hong Kong alongside its current U.S. listing, aiming to ease U.S. regulatory pressure and reach more Chinese investors
Lukewarm interest in the new Hong Kong offering suggests investors are concerned about the company’s growing losses
By Jony Ho